RA 642 | CAS#54093-30-0 | PDE-inhibitor

MedKoo Cat#: 461105 | Name: RA 642

Description:

WARNING: This product is for research use only, not for human or veterinary use.

RA 642 is a PDE-inhibitor.

Chemical Structure

RA 642

CAS#54093-30-0

Theoretical Analysis

MedKoo Cat#: 461105

Name: RA 642

CAS#: 54093-30-0

Chemical Formula: C24H44N8O4

Exact Mass: 508.3486

Molecular Weight: 508.66

Elemental Analysis: C, 56.67; H, 8.72; N, 22.03; O, 12.58

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

RA 642; RA-642; RA642; RA 642BS; RA-642BS; RA642BS; RXRA 642; RXRA-642; RXRA642;

IUPAC/Chemical Name

2,2'-((4,8-bis(diethylamino)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis((2-methoxyethyl)azanediyl))bis(ethan-1-ol)

InChi Key

ROFXYKJBKWRUBS-UHFFFAOYSA-N

InChi Code

InChI=1S/C24H44N8O4/c1-7-29(8-2)21-19-20(26-23(27-21)31(11-15-33)13-17-35-5)22(30(9-3)10-4)28-24(25-19)32(12-16-34)14-18-36-6/h33-34H,7-18H2,1-6H3

SMILES Code

CCN(CC)c1c2c(c(N(CC)CC)nc(N(CCOC)CCO)n2)nc(N(CCOC)CCO)n1

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 508.66 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Jonkman FA, Thoolen MJ, Wilffert B, de Jonge A, Timmermans PB, Van Zwieten PA. Effect of salbutamol and the PDE-inhibitor RA 642 on the clonidine withdrawal syndrome in rats. J Auton Pharmacol. 1984 Sep;4(3):199-206. PubMed PMID: 6092386. 2: de la Cruz JP, Moreno A, Mérida F, García-Campos J, Sánchez de la Cuesta F. The pyrimido-pyrimidine derivatives, dipyridamole and RA-642, reduce opacification of crystalline lens in diabetic rats. Pharmacol Toxicol. 1994 Nov;75(5):250-4. PubMed PMID: 7870694. 3: De La Cruz JP, Villalobos MA, Carrasco T, Smith-Agreda JM, Sánchez de la Cuesta F. The pyrimido-pyrimidine derivative RA-642 protects from brain injury in a combined model of permanent focal ischemia and global ischemia reperfusion. Brain Res. 1992 Dec 4;597(2):250-6. PubMed PMID: 1472997. 4: Hock CE, Lefer DJ, Lefer AM. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642. Methods Find Exp Clin Pharmacol. 1986 May;8(5):265-9. PubMed PMID: 3724301. 5: Bellido I, de la Cruz JP, Sánchez de la Cuesta F. The pyrimido-pyrimidine derivative RA-642: a potent inhibitor of ferrous-induced lipid peroxidation in cell membranes. Methods Find Exp Clin Pharmacol. 1991 Jul-Aug;13(6):371-5. PubMed PMID: 1881198. 6: De la Cruz JP, Olveira C, Gonzalez-Correa JA, Benítez A, Sánchez de la Cuesta F. Inhibition of ferrous-induced lipid peroxidation by dipyridamole, RA-642 and mopidamol in human lung tissue. Gen Pharmacol. 1996 Jul;27(5):855-9. PubMed PMID: 8842690. 7: De la Cruz JP, Sintas A, Moreno A, Garcia-Campos J, Sanchez de la Cuesta F. Dipyridamole and RA-642 inhibit the production of superoxide anion and free radical damage to rat lens. Pharmacol Toxicol. 1991 Sep;69(3):201-4. PubMed PMID: 1665562. 8: De La Cruz JP, Moreno A, Mérida F, García Campos J, Sánchez de la Cuesta F. The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus. Thromb Res. 1996 Feb 1;81(3):327-37. PubMed PMID: 8928090. 9: de la Cruz JP, Moron D, Sanchez de la Cuesta F. Antiplatelet effect of the pyrimido-pyrimidinic derivative RA-642. Thromb Res. 1991 Aug 15;63(4):463-8. PubMed PMID: 1754999. 10: Hergenröder S, Reichl R. Pharmacological effects of RA 642 on cerebrocortical perfusion in acute hemorrhagic shock in rats. Prog Clin Biol Res. 1989;308:1091-5. PubMed PMID: 2780688. 11: Boswell GW, Munoz AC, Aaron DT, Chin CL, Quinn KP. High-performance liquid chromatographic assay for RA 642, a compound with cardiovascular effect, in human and rabbit serum alpha. J Chromatogr. 1989 Jul 21;491(2):513-8. PubMed PMID: 2808637. 12: Yin M, Liao XL, Tan SJ. [Effects of 2,2'-[(4,8-bis(diethylamino)-pyrimido[5,4-d]pyrimidine-2,6-diyl) di-(2-methoxyethyl)imino]diethanol (RA 642) on experimental scald shock]. Zhongguo Yao Li Xue Bao. 1987 Nov;8(6):533-6. Chinese. PubMed PMID: 3451667. 13: de la Cruz JP, Carrasco T, Ortega G, Sanchez de la Cuesta F. Inhibition of ferrous-induced lipid peroxidation by pyrimido-pyrimidine derivatives in human liver membranes. Lipids. 1992 Mar;27(3):192-4. PubMed PMID: 1522764. 14: Aibiki M, Koyama S, Kanai K, Fujita T, Miyakawa K. [A comparison of effects on renal sympathetic nerve responses to RA642 and catecholamines during hemorrhagic shock in anesthetized rabbits]. Masui. 1988 May;37(5):561-9. Japanese. PubMed PMID: 3411779. 15: Koyama S. Characteristic cardiovascular effects of RA642, a pyrimido-pyrimidine derivative, in anesthetized dogs. J Pharmacol Exp Ther. 1985 May;233(2):480-4. PubMed PMID: 3999030. 16: Koyama S, Manning JW, Takeuchi T. Pyrimido-pyrimidine derivative, RA642, a central pressor agent in cat endotoxin shock. Eur J Pharmacol. 1982 Sep 24;83(3-4):191-8. PubMed PMID: 6293839. 17: Aibiki M, Koyama S, Fujita T. Effects of RA642, a new central pressor agent, on renal sympathetic nerve activity and blood pressure during hemorrhagic shock in rabbits. Circ Shock. 1991 Jun;34(2):240-6. PubMed PMID: 1934324. 18: Koyama S. Cardiovascular improvement due to RA642, a pyrimido-pyrimidine derivative, in canine endotoxin shock. Circ Shock. 1984;13(4):341-51. PubMed PMID: 6478548.